谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

A Phase II, Open Label, Single Arm Study of Nivolumab for Recurrent or Progressive IDH Mutant Gliomas with Prior Exposure to Alkylating Agents.

Eunji Yim,Laura Donovan,Alicia Bargo,Lakshmi Nayak,Yazmin Odia,Eric Wong, Krystelle Pring, Mervin Malig, Yacha Genfi, Nathaniel Wright, Lakshmi Kesari,Alyssa Russ, Rae Chang, Denisse Torres, Kriti Bagri Manjrekar,Sarah Sta Ana,Naomi Sender,Suzanne Mistretta,Fabio Iwamoto

NEURO-ONCOLOGY（2024）

引用 0|浏览23
关键词
IDH Mutation
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要